Harlan Waksal is the founder of Kadmon. Kadmon has raised $500M in total funding. Latest round: IPO. Based in New York, United States.
Harlan Waksal is a biotech executive and co-founder of Kadmon, a New York-based drug developer focused on cancer, inflammatory, and metabolic treatments. He is the son of Sam Waksal, the former ImClone CEO, and has reunited with his brother to advance Kadmon's pipeline.
Full founder directory · Investor directory · Company funding database · Fundraising library